Home/Corvus Pharmaceuticals/Otute Akiti, Ph.D.
OA

Otute Akiti, Ph.D.

Vice President, CMC

Corvus Pharmaceuticals

Therapeutic Areas

Corvus Pharmaceuticals Pipeline

DrugIndicationPhase
Soquelitinib (CPI-818)Relapsed/Refractory T Cell LymphomasPhase 1/1b